Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Week in Review: High-risk HF patients | AFIb & alcohol | A historic FDA approval | Insulin syringes recalled
Saturday, June 26, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

New metric identifies heart failure patients facing a higher risk of hospitalization or death

This new measurement, researchers explained, can help clinicians target high-risk patients with more aggressive treatments. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

New metric identifies heart failure patients facing a higher risk of hospitalization or death

Share on Twitter Share on Facebook Share on Linkedin
This new measurement, researchers explained, can help clinicians target high-risk patients with more aggressive treatments. 
READ MORE >

Time for a change? AFib patients may want to stop drinking alcohol

Alcohol consumption is associated with a heightened risk of stroke among patients with newly diagnosed atrial fibrillation.

READ MORE >
alcoholshotdrink.jpg
Share on Twitter Share on Facebook Share on Linkedin

Time for a change? AFib patients may want to stop drinking alcohol

Share on Twitter Share on Facebook Share on Linkedin
alcoholshotdrink.jpg
Alcohol consumption is associated with a heightened risk of stroke among patients with newly diagnosed atrial fibrillation.
READ MORE >

FDA approves first oral blood thinner for pediatric patients

The approval includes patients as young as three months old. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first oral blood thinner for pediatric patients

Share on Twitter Share on Facebook Share on Linkedin
The approval includes patients as young as three months old. 
READ MORE >

Think before you eat: How eating patterns in the US increase risk of cardiovascular disease, death

The study's authors examined data from more than 21,000 participants. 

READ MORE >
deli_sandwich_lunch_food.jpg
Share on Twitter Share on Facebook Share on Linkedin

Think before you eat: How eating patterns in the US increase risk of cardiovascular disease, death

Share on Twitter Share on Facebook Share on Linkedin
deli_sandwich_lunch_food.jpg
The study's authors examined data from more than 21,000 participants. 
READ MORE >

Man had heart attack after consuming 12 energy drinks per day—now he’s warning others

The 53-year-old said he had no idea they were bad for him until after his heart attack. He has now stopped drinking energy drinks altogether. 

READ MORE >
Sen. Chunk Schumer has asked the U.S. Food and Drunk Administration (FDA) to investigate the high amount of caffeine found in energy drinks sold by Prime, a beverage brand founded by YouTube personalities Logan Paul and KSI. According to Schumer, the “eye-popping 200 mg of caffeine” found in a single Prime energy drink is troubling, especially for a product marketed primarily to children.
Share on Twitter Share on Facebook Share on Linkedin

Man had heart attack after consuming 12 energy drinks per day—now he’s warning others

Share on Twitter Share on Facebook Share on Linkedin
Sen. Chunk Schumer has asked the U.S. Food and Drunk Administration (FDA) to investigate the high amount of caffeine found in energy drinks sold by Prime, a beverage brand founded by YouTube personalities Logan Paul and KSI. According to Schumer, the “eye-popping 200 mg of caffeine” found in a single Prime energy drink is troubling, especially for a product marketed primarily to children.
The 53-year-old said he had no idea they were bad for him until after his heart attack. He has now stopped drinking energy drinks altogether. 
READ MORE >

Medtronic gains expanded FDA approval for Arctic Front cryoablation catheters

The full Arctic Front line is now approved as a first-line treatment for heart rhythm issues. 

READ MORE >
approved approval
Share on Twitter Share on Facebook Share on Linkedin

Medtronic gains expanded FDA approval for Arctic Front cryoablation catheters

Share on Twitter Share on Facebook Share on Linkedin
approved approval
The full Arctic Front line is now approved as a first-line treatment for heart rhythm issues. 
READ MORE >

Statin therapy not associated with dementia or cognitive decline

This was found to be true for patients taking both hydrophilic and lipophilic statins.

READ MORE >
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.
Share on Twitter Share on Facebook Share on Linkedin

Statin therapy not associated with dementia or cognitive decline

Share on Twitter Share on Facebook Share on Linkedin
Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.
This was found to be true for patients taking both hydrophilic and lipophilic statins.
READ MORE >

FDA announces recall of multiple lots of Smiths Medical insulin syringes

This is a Class I recall, which means the issue could lead to serious injury or death.

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of multiple lots of Smiths Medical insulin syringes

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
This is a Class I recall, which means the issue could lead to serious injury or death.
READ MORE >

Valve-in-valve TAVR outcomes ‘excellent’ after one year

Moderate to severe aortic regurgitation was seen in 0.9% of patients after 30 days and 1.3% after one year.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Valve-in-valve TAVR outcomes ‘excellent’ after one year

Share on Twitter Share on Facebook Share on Linkedin
Moderate to severe aortic regurgitation was seen in 0.9% of patients after 30 days and 1.3% after one year.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme